UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 9, 2005 (November 4, 2005)
AMPLIDYNE, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-21931 22-3440510
-------- ------- ----------
(State or Other (Commission File No.) (IRS Employer
Jurisdiction of Identification No.)
Incorporation)
59 LaGrange Street
Raritan, New Jersey 08869
-------------------------
(Address of Principal Executive Office)
(908) 253-6870
--------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act
Section 5 - Corporate Governance and Management
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On November 4, 2005, the Registrant amended its Certificate of
Incorporation to (a) change its name to Wi-Tron, Inc., (b) increase the
authorized shares of common stock, $.0001 par value, from 25,000,000 shares to
100,000,000 shares of common stock, and (c) increase the authorized shares of
preferred stock, $.0001 par value, from 1,000,000 to 5,000,000 shares of
preferred stock.
Section 9 - Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
3.1 Certificate of Amendment to Certificate of Incorporation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereto duly authorized.
AMPLIDYNE, INC.
Date: November 4, 2005 By: /s/ John Chase Lee
---------------------------
John Chase Lee, President